Scleroderma, Systemic: Clinical Trials

179 trials for Scleroderma, Systemic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

93 completed, 31 unknown, 24 recruiting, 10 not yet recruiting. 179 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable179Completed 93, Unknown 31, Recruiting 24, Not yet recruiting 10, Terminated 10, Active not recruiting 7, Withdrawn 3, Enrolling by invitation 1

Follow Scleroderma, Systemic: new trials by email Literature Review of Scleroderma, Systemic trials Research Report on Scleroderma, Systemic

Trials (filtered) newest first · largest first

All 179 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Investigation of Type I Interferon Excess in Patients With Systemic Autoimmune Diseases and Genetic Type I Interferonopathies
biological samples - Systememic Lupus Erythematosus, Systemic Sclerosis (SSc)
Not applicableNot yet recruitingHospices Civils de Lyon1202026-12-012026-09-24
Using AI-Assisted Cameras to Track Hand Exercises in Scleroderma Patients
AI-powered, camera-based, exercise-focused telerehabilitation, Physiotherapist-supervised, exercise-focused rehabilitation - Systemic Scleroderma
Not applicableNot yet recruitingIstanbul University - Cerrahpasa402026-11-012026-10-14
Small Airway Dysfunction in Rheumatoid Arthritis and Systemic Sclerosis
Conventional PFT; IOS; CANO; Chest HRCT - Rhumatoid Arthisis, Systemic Sclerosis (SSc)
Not applicableNot yet recruitingAssistance Publique - Hôpitaux de Paris1842026-11-012026-11-09
Tissue Modeling in Systemic Sclerosis Using Induced Pluripotent Stem Cells (iPSCs)
Blood Sample Collection - Systemic Sclerosis (SSc)
Not applicableRecruitingUniversity Hospital, Montpellier162026-10-272026-10-29
Home-based Exercise for Improving Health-related Quality of Life in Systemic Sclerosis
Home-based exercise programme, Usual Care - Systemic Sclerosis (SSc)
Not applicableNot yet recruitingUniversity of Aarhus2702026-10-152026-09-25
Extracellular Vesicle Dynamics Predicting Vascular Complications and Treatment Response in Systemic Sclerosis
Blood sampling, nailfold capillaroscopy - Systemic Sclerosis, Pulmonary Arterial Hypertension
Not applicableNot yet recruitingFondazione Policlinico Universitario Agostino Gemelli IRCCS602026-09-012026-07-21
Personalized Online Occupational Therapy Intervention for Adults With Scleroderma
Personalized Online Occupational Therapy Intervention, Usual Care - Scleroderma, Scleroderma (Limited and Diffuse)
Not applicableCompletedUniversidad de Zaragoza242026-05-162026-10-14
Exploratory Clinical Study of Anti-CD19/BCMA Universal CAR-T Cell Injection for the Treatment of Refractory Autoimmune Diseases
anti-CD19/BCMA-UCAR-T cells - Rheumatoid Arthritis, Dermatomyositis
Not applicableRecruitingThe First Affiliated Hospital with Nanjing Medical University722026-05-102026-04-30
Objective Assessment of Skin Damage Using ADHELASKIN in Patients With Systemic Sclerosis
ADHELASKIN (Tactinnov° - Ecole centrale de Lyon) - D013493
Not applicableRecruitingCentre Hospitalier Universitaire de Saint Etienne1002026-05-072026-07-31
Efficacy and Safety of Firsekibart in the Treatment of Systemic Sclerosis
Firsekibart injection - Systemic Scleroderma
Not applicableNot yet recruitingTongji Hospital302026-05-012026-04-20
The Effect of Progressive Muscle Relaxation Exercises on Fatigue, Dyspnea, and Respiratory Function in Patients With Systemic Sclerosis
Progressive Muscle Relaxation Exercise - Systemic Sclerosis (SSc)
Not applicableRecruitingUniversity of Gaziantep502026-04-252026-10-08
Systemic Sclerosis DIet for GastrointESTinal Symptoms
Diet 1: Restriction of fermentable carbohydrates, Diet 2: Elimination of foods harmful to gut barrier and microbiome, Diet 3: Regular meal patterns, soluble fiber, and portion control - Systemic Sclerosis (SSc)
Not applicableRecruitingUniversity of Michigan602026-03-162026-07-01
Clinical Study of EVM18001 in the Treatment of Refractory Autoimmune Diseases
EVM18001 Injection - System Lupus Erythematosus(SLE), Scleroderma
Not applicableRecruitingUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology122026-03-122026-03-13
A Study of CD19 UCAR-T Cells in Subjects With Autoimmune Diseases
CD19 UCAR-T cells - Systemic Lupus Erythematosus, Idiopahic Inflammatory Myopathies
Not applicableNot yet recruitingInstitute of Hematology & Blood Diseases Hospital, China242026-01-302025-12-19
Safety and Efficacy of Adipose-Derived Regenerative Cells (ADRCs) for Improving Hand Dysfunction in Systemic Sclerosis
Autologous ADRCs injection Combined with Standard Therapy, Standard Treatment group - Systemic Sclerosis (SSc), Hand Dysfunction
Not applicableRecruitingCytori Therapeutics482025-12-312026-01-22
Evaluating Tools to Communicate Scleroderma Research Results to Patients - Trial #1
Plain-language summary, Dissemination Tool (Infographic) - Scleroderma, Systemic Sclerosis
Not applicableCompletedLady Davis Institute5112025-12-052026-09-10
Investigating the Effectiveness of the Biopsychosocial Model-Based Exercise Approach in Children and Adults Diagnosed With Scleroderma
Cognitive Exercise Therapy Approach, Control group - Scleroderma, Scleroderma, Localized
Not applicableRecruitingHacettepe University482025-12-042025-12-18
Diffuse Cutaneous Scleroderma (DSSc) SFDI Study
Spatial-frequency domain imaging (SFDI) - Systemic Scleroderma, Diffuse Cutaneous Scleroderma
Not applicableRecruitingBoston University652025-11-062026-07-23
Anti CD19/BCMA CAR Gene Therapy for Autoimmune Diseases
Anti-CD19/BCMA CAR gene vector injection will be injected intravenously on a one-time basis - Autoimmune Diseases
Not applicableRecruitingAnhui Provincial Hospital182025-08-252025-08-13
CAR-T Cells Therapy for Patients With Autoimmune Diseases
Anti-BCMA and CD19 CART cells will be injected intravenously on a one-time basis - Autoimmune Diseases
Not applicableRecruitingAnhui Provincial Hospital182025-07-202025-07-08

Showing 20 of 179. Sign in to see all of them.

Narrower conditions

Scleroderma, Diffuse (79)  ·  Lupus Erythematosus, Systemic (18)  ·  Arthritis, Rheumatoid (10)  ·  Motor Activity (10)  ·  Sjogren's Syndrome (10)  ·  Myositis (9)  ·  Raynaud Disease (8)  ·  Autoimmune Diseases (7)  ·  digital ulcers (6)  ·  Antiphospholipid Syndrome (5)  ·  Fatigue (5)  ·  Hypertension, Pulmonary (5)  ·  Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (4)  ·  Connective Tissue Diseases (4)

Broader conditions

Skin Diseases (179)  ·  Skin and Connective Tissue Diseases (179)  ·  Connective Tissue Diseases (175)  ·  Immune System Diseases (28)  ·  Pathological Conditions, Signs and Symptoms (27)  ·  Musculoskeletal Diseases (25)  ·  Cardiovascular Diseases (23)  ·  Vascular Diseases (22)  ·  Autoimmune Diseases (19)  ·  Joint Diseases (19)  ·  Pathologic Processes (17)  ·  Respiratory Tract Diseases (17)  ·  Arthritis (16)  ·  Nervous System Diseases (16)

Interventions

Blood Specimen Collection (11)  ·  Exercise (3)  ·  Rehabilitation (3)  ·  Biopsy (2)  ·  Hematologic Tests (2)  ·  Occupational Therapy (2)  ·  ambrisentan (2)  ·  Ambulatory Care Facilities (1)  ·  Biofeedback, Psychology (1)  ·  Bosentan (1)  ·  Botulinum Toxins, Type A (1)  ·  Butylated Hydroxytoluene (1)  ·  Cholecalciferol (1)  ·  Clinical Protocols (1)  ·  Cognitive Behavioral Therapy (1)

Sponsors

University of Michigan (12)  ·  Lady Davis Institute (9)  ·  Assistance Publique - Hôpitaux de Paris (7)  ·  Istanbul University (7)  ·  University Hospital, Strasbourg, France (6)  ·  Assistance Publique Hopitaux De Marseille (4)  ·  Echosense Ltd. (4)  ·  Poitiers University Hospital (4)  ·  University Hospital, Lille (4)  ·  Assiut University (3)  ·  Firat University (3)  ·  Pamukkale University (3)  ·  University Hospital, Bordeaux (3)  ·  University Hospital, Grenoble (3)  ·  Anhui Provincial Hospital (2)

Countries

France (39)  ·  United States (35)  ·  Turkey (Türkiye) (20)  ·  China (14)  ·  Canada (12)  ·  Italy (7)  ·  Germany (5)  ·  Israel (4)  ·  Brazil (3)  ·  South Korea (3)  ·  Spain (3)  ·  United Kingdom (3)  ·  Austria (2)  ·  Belgium (2)  ·  Denmark (2)

Top investigators

David Launay, MD,PhD (3)  ·  Luc Mouthon, MD, PhD (3)  ·  Andreea Bujor, MD, PhD (2)  ·  Brett D Thombs, PhD (2)  ·  Brett Thombs, PhD (2)  ·  Robyn T Domsic, MD (2)  ·  Susan Murphy (2)  ·  Alexsandra Balbir, Dr (1)  ·  Ali Ismail, lecturer (1)  ·  Amar Smail, MD (1)

Results publications

PMID 29381834, PMID 16960939, PMID 17234649, PMID 21312348, PMID 21476099, PMID 21951278, PMID 22127844, PMID 22470237, PMID 24475856, PMID 24507585, PMID 24812476, PMID 24990822, PMID 25114060, PMID 27384349, PMID 27429171, PMID 27696703, PMID 27941129, PMID 28081972, PMID 28552512, PMID 29198478, PMID 29325173, PMID 29444467, PMID 29667474, PMID 29685482, PMID 29696997, PMID 29741230, PMID 29781586, PMID 29871697, PMID 30072999, PMID 30079996, PMID 30092330, PMID 30318128, PMID 30463598, PMID 30616671, PMID 30809542, PMID 30835186, PMID 30886963, PMID 30886964, PMID 31130325, PMID 31216880, PMID 31219594, PMID 31220505, PMID 31482431, PMID 31719073, PMID 31933034, PMID 32062031, PMID 32493508, PMID 32633087, PMID 32927933, PMID 33117350

NIH funding

2017 (1), R01AR081382 (1), R01AR085317 (1)